U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H28N4O4
Molecular Weight 412.4821
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AQ4

SMILES

CN(C)CCNC1=C2C(=O)C3=C(C(O)=CC=C3O)C(=O)C2=C(NCCN(C)C)C=C1

InChI

InChIKey=DBAMBJQJKDHEQX-UHFFFAOYSA-N
InChI=1S/C22H28N4O4/c1-25(2)11-9-23-13-5-6-14(24-10-12-26(3)4)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30/h5-8,23-24,27-28H,9-12H2,1-4H3

HIDE SMILES / InChI

Molecular Formula C22H28N4O4
Molecular Weight 412.4821
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 17:15:26 UTC 2023
Edited
by admin
on Fri Dec 15 17:15:26 UTC 2023
Record UNII
QXB9LEJ2B2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AQ4
Common Name English
BIS((2-(DIMETHYLAMINO)ETHYL)AMINO)-5,8-DIHYDROXYANTHRAQUINONE, 1,4-
Systematic Name English
Code System Code Type Description
CAS
70476-63-0
Created by admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
PRIMARY
FDA UNII
QXB9LEJ2B2
Created by admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
PRIMARY
EPA CompTox
DTXSID00220741
Created by admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
PRIMARY
PUBCHEM
135468
Created by admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
PRODRUG -> METABOLITE ACTIVE
Reduction of AQ4N to the mono N-oxide intermediate AQ4M [ 1-{[2-(dimethylamino-N-oxide)ethyl]amino}-4-{[2-(dimethylamino) ethyl]amino}-5,8-dihydroxyanthracene-9,10-dione] and finally to AQ4 provides a mechanism for selectively generating the active topoisomerase inhibitor within hypoxic cancer cells.